In summary, this study demonstrates that low doses of orally administered silkworm-produced CTB-Ins-GFP protein can effectively suppress the development of diabetes in NOD mice, where the treatment function involves inducing CD4+CD25+Foxp3+ Treg cells. Here, FOXP3 is linked to diabetes mellitus.